NCT02710773

Brief Summary

Gait impairment is a common cause of disability in patients who have experienced a stroke and recovery of walking is a priority goal. Gait outcome is a significant factor that influences a patient's chance of returning to the social life activity and rehabilitation is an effective treatment for restoring gait in these patients. Learning to walk backwards correctly has been recommended to improve the movement components required for walking forwards. Several studies demonstrated that during backward walking the muscle activity is higher, more oxygen consumption, metabolic and cardiorespiratory activity are required and the same motor program is used comparing to during the forward walking. It has been suggested that backward walking therapy may be promoted as a treatment strategy to improve gait in stroke patients. The main goal of this project is to investigate the effectiveness of the backward walking therapy on gait improvement and spasticity in post stroke patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2016

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 17, 2016

Completed
15 days until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

September 7, 2016

Status Verified

September 1, 2016

Enrollment Period

7 months

First QC Date

February 23, 2016

Last Update Submit

September 6, 2016

Conditions

Keywords

GaitRandomized controlled trialChronic StrokeTreadmill training

Outcome Measures

Primary Outcomes (1)

  • 10 meters Walking test (10-MtWT) change in gait speed

    the test has been selected as a measure of gait speed. This is a validated test requiring individuals to walk on a flat hard floor at their fastest speed foe 10 meters. Scoring is walking speed.

    Baseline time 0 and up to 16 weeks

Secondary Outcomes (7)

  • Gait analysis

    Baseline time 0 and up to 16 weeks

  • Stroke Impact scale

    Baseline time 0 and up to 16 weeks

  • Health Survey Questionnaire short form 36

    Baseline time 0 and up to 16 weeks

  • Modified Ashworth Scale

    Baseline time 0 and up to 16 weeks

  • Modified "Tardieu" Scale

    Baseline time 0 and up to 16 weeks

  • +2 more secondary outcomes

Study Arms (2)

Backward Walking Treadmill Training

EXPERIMENTAL

The subjects will perform a backward walking training on treadmill device

Other: Backward Walking Treadmill Training

Treadmill training

ACTIVE COMPARATOR

The subjects will perform a walking training on treadmill device

Other: Treadmill Training

Interventions

The intervention will consist of 5 minutes of forward walking (warm-up phase), 10 minutes of backward walking (intervention phase) and 5 minutes of forward walking (cool-down phase). The session will be performed on a treadmill device. The backward training speed will be increase consecutively: during the week 1, the intervention will be performed at 0,8 km/h; during the week 2 the speed will be 1,0 km/h; finally, during the week 3 the speed will be increased till 1,2 km/h.

Backward Walking Treadmill Training

The intervention will consist of 20 minutes of forward walking on a treadmill device.

Treadmill training

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of ischemia brain injury or intracerebral hemorrhage by MRI or computed tomography at least 6 months before the onset of the study;
  • age between 18 and 75 years;
  • ability to walk independently for at least 15 meters;
  • Functional Ambulatory Category level score 2 or less;
  • Ability to walk in the treadmill at \>0.3 km/h for 3 minutes handrail support;

You may not qualify if:

  • presence of other concurrent neurological or orthopaedic diseases involving the lower limbs and/or interfering with standing position and/or walking;
  • aphasia with inability to follow 2 consecutive step commands, or a cognitive deficit;
  • any uncontrolled health condition for which exercise is contraindicated
  • Mini Mental State Examination \<20;
  • Unstable angina pectoris;
  • Unstable cardiac conditions;
  • Complex ventricular arrhythmia;
  • Resting systolic blood pressure \>200 mm/Hg - Resting diastolic blood pressure \>100 mm/Hg;
  • Aphasia (unable to follow two commands);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienta Ospedaliera, SSO Rehabilitation Unit, Verona

Verona, Italy, Verona, 37134, Italy

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Nicola Nicola, MD

    Neuromotor and Cognitive Rehabilitation Center Department of Neurological, Neuropsychological, Morfological and Motor Sciences University of Verona, Verona, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alessandro Picelli, MD

CONTACT

Daniele Munari, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

February 23, 2016

First Posted

March 17, 2016

Study Start

April 1, 2016

Primary Completion

November 1, 2016

Study Completion

December 1, 2016

Last Updated

September 7, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations